Fuso Pharmaceutical Industries,Ltd. (TYO:4538)

TYO:4538 Revenue

Fuso Pharmaceutical Industries,Ltd. had revenue of 16.05B JPY in the quarter ending June 30, 2026, with 3.50% growth. This brings the company's revenue in the last twelve months to 62.85B, up 2.29% year-over-year. In the fiscal year ending March 31, 2026, Fuso Pharmaceutical Industries,Ltd. had annual revenue of 62.31B with 2.88% growth.

• Revenue (ttm): 62.85B
• Revenue Growth: +2.29%
• P/S Ratio: 0.31
• Revenue / Employee: 45.88M
• Employees: 1,370
• Market Cap: 19.76B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	62.31B	1.74B	2.88%
Mar 31, 2025	60.56B	5.16B	9.31%
Mar 31, 2024	55.41B	6.80B	13.98%
Mar 31, 2013	48.61B	4.25B	9.59%
Mar 31, 2012	44.36B	-3.11B	-6.55%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error